CAS: 21590-92-1; Etomidoline

该化合物是属于异丁酮类的化学化合物.该物质通常具有复杂的分子结构,其特点是有异丁烯核,与管道性软体和代氧苯组结合.该化合物在室温下很固,由于其疏水性特点,有机溶剂中具有中等溶解性.它可能表现出生物活动,可能作为一种药剂作用,尽管具体的生物特性取决于其在分子一级的相互作用.管状环的存在表明它有可能与生物目标,如受体或酶发生相互作用.与许多有机化合物,安全和处理预防措施一起,如果管理不当,可能会对健康造成风险.进一步的研究将有必要充分阐明其特性和在医学或其他领域应用的可能性.

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      📜邻羧基苯甲醛,4-(2-哌啶-1-乙氧基)-苯胺,C.I.酸性橙108 反应生成依托多林
      参考文献:Fudzimoto,Dotaro;Funadzo,Giiti;Fukui,Ryuiti;Takamatsu,Syuxehj;Sakai,+
      标题:Fudzimoto,Dotaro;Funadzo,Giiti;Fukui,Ryuiti;Takamatsu,Syuxehj;Sakai,+

      海关参考信息

      专利信息


      专利号:US-3772366-A
      优先权日:1964-09-29
      标 题 :Process for the preparation of 9beta,10beta steroids
      发明人:USKOKOVIC M; WILLIAMS T
      权利人:HOFFMANN LA ROCHE
      摘要:THE PRESENT INVENTION IS DIRECTED TO A PROCESS FOR THE COMPLETE CHEMICAL SYNTHESIS OF STEROIDS HAVING THE 9B, 10A-CONFIGURATION FROM THE NATURAL STERIOIDS POSSESSING THE 9A, 10B-CONFIGURATION INCLUDING INTERMEDIATES IN THIS SYNTHESIS. THE STEROIDS WITH THE 9B,10A-CONFIGURATION ARE USEFUL AS ANABOLIC AGENTS, ANTI-ANDROGENIC AGENTS, PROGESTATIONAL AGENTS AND AS SALT-RETAINING AGENTS.

      专利号:US-8734846-B2
      优先权日:2008-06-16
      标 题 :Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles
      发明人:ALI MIR M; HRKACH JEFF; ZALE STEPHEN E; ALVAREZ DE CIENFUEGOS LUIS
      权利人:BIND BIOSCIENCES INC
      摘要:This application provides nanoparticles and methods of making nanoparticles using pre-functionalized poly(ethylene glycol)(also referred to as PEG) as a macroinitiator for the synthesis of diblock copolymers. Ring opening polymerization yields the desired poly(ester)-poly (ethylene glycol)-targeting agent polymer that is used to impart targeting capability to therapeutic nanoparticles. This “polymerization fromâ€? approach typically employs precursors of the targeting agent wherein the reactivity of functional groups of the targeting agent is masked using protecting groups. Also described is a “coupling toâ€? that utilized the poly(ethylene glycol)-targeting agent conjugate where the targeting agent remains in its native un-protected form. This method uses “orthogonalâ€? chemistry that exhibit no cross reactivity towards functional groups typically found within targeting agents of interest.

      专利号:US-2013035307-A1
      优先权日:2010-01-26
      标 题:Methods for treating or preventing the spread of cancer using semi-synthetic glycosaminoglycosan ethers
      发明人:PRESTWICH GLENN D; KENNEDY THOMAS P
      权利人:UNIV UTAH RES FOUND; PRESTWICH GLENN D; KENNEDY THOMAS P
      摘要:Described herein are methods for the treatment and prevention of tumor metastasis using alkylated and fluoroalkylated semi-synthetic glycosaminoglycan ethers (“SAGEsâ€?). The synthesis of sulfated alkylated and fluoroalkylated SAGEs is also described.

      专利号:US-2008214827-A1
      优先权日:2004-02-03
      标 题:Synthesis of Cyanoimino-Benzoimidazoles
      发明人:GOEHRING R RICHARD; WHITEHEAD JOHN; SHAO BIN
      权利人:EURO CELTIQUE SA
      摘要:Disclosed in certain embodiments is a process for synthesizing a compound of formula (V) and salts thereof.

      专利号:US-5219741-A
      优先权日:1989-09-06
      标题:Method of making L-proline using an N-acyl-L-protine acylase
      发明人:GROEGER ULRICH; LEUCHTENBERGER WOLFGANG; DRAUZ KARLHEINZ
      权利人:DEGUSSA
      摘要:A microbiologically produced, thermostable N-acylproline-acylase and a process for obtaining it from Comamonas testosteroni DSM 5416 and Alcaligenes denitrificans DSM 5417. The enzyme is useful for the synthesis of L-proline from various N-acyl-L-proline derivatives.

      专利号:US-2024382626-A1
      优先权日:2023-05-16
      标题 :Irradiation amenable liposomal dye aggregates and methods of synthesis and use thereof
      发明人:PORTER TYRONE; STERN NOAH; TUNNELL JAMES; SHRESTHA BINITA
      权利人:UNIV TEXAS
      摘要:The present invention provides lipid nanoparticles that are amenable to an irradiation at a wavelength at or above 850 nm, have an absorption peak from about 850 to 1100 nm wavelength, and comprise a high transition temperature lipid and a dye (e.g., a J-aggregate of a dye). In some embodiments, the dye (e.g., J-aggregate of the dye) is encapsulated in the lipid nanoparticle. In various embodiments, the present invention also relates to compositions comprising said lipid nanoparticles and methods of generating said lipid nanoparticles and compositions thereof. The present invention further relates to methods relating to the said lipid nanoparticles for imaging, detection, and treatment of diseases or disorders (e.g., phototherapy) in a subject.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      合成参考文献


      摘要:Kiso to Rinsho. Clinical Report., 8(1730), 1974
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知